Leaflet LITHIUM CARBONICUM GSK 250mg tablets

Indicated for: bipolar disorder

Route of administration: oral

Substance: lithium carbonate (antipsychotic)

ATC: N05AN01 (Nervous system | Antipsychotics | Lithium)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Hyperglycemia
Hyperglycemia

This medicine may increase blood sugar.

Cardiac risk / QT prolongation / arrhythmias
Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

Seizure risk
Seizure risk

This medicine may increase the risk of seizures.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Lithium carbonate is a medication used for the treatment of bipolar disorder, particularly for the prevention of manic and depressive episodes. It works by stabilizing neurotransmitter activity in the brain.

The medication is taken orally, usually two to three times a day, and the dose is adjusted based on blood lithium levels. Regular monitoring of serum lithium levels is essential to avoid toxicity.

Side effects may include tremor, nausea, diarrhea, or weight gain. In rare cases, toxicity may occur with symptoms such as confusion, seizures, or kidney failure.

Lithium carbonate is not recommended for patients with severe renal impairment, dehydration, or hypersensitivity to this medication. It is important to avoid excessive salt intake and maintain adequate hydration during treatment.

General data about LITHIUM CARBONICUM GSK 250mg

  • Substance: lithium carbonate
  • Date of latest medicines list: 01-08-2021
  • Product code: W54312001
  • Concentration: 250mg
  • Pharmaceutical form: tablets
  • Quantity: 60
  • Product type: Original
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: GLAXO SMITHKLINE PHARMACEUTICALS S.A. - POLONIA
  • Holder: CN UNIFARM S.A. - ROMANIA
  • Number: 480/2020/01
  • Shelf life: 3 years